NCT00518232View on ClinicalTrials.gov

A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

OROS-methylphenidate

Sponsors
All Listed Sponsors
lead

Johnson & Johnson Taiwan Ltd

INDUSTRY